Response to Concerns Regarding Intensive Chemoprophylaxis During Influenza Outbreaks in Nursing Homes
-
By
-
Andrew R. Zullo
-
Joe B. B. Silva
-
Stefan Gravenstein
-
September 1, 2026
Response to Concerns Regarding Intensive Chemoprophylaxis During Influenza Outbreaks in Nursing Homes
Background
Influenza outbreaks in nursing homes pose significant risks to elderly residents, often resulting in increased morbidity and mortality. The Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) recommend prompt antiviral prophylaxis to mitigate these risks.
Data Highlights
No numerical data provided in the source material.
Key Findings
- Oseltamivir chemoprophylaxis was assessed using electronic medication administration records (eMAR) rather than clinician orders.
- Substantial unmeasured oseltamivir use in the nonintensive group is unlikely due to the controlled medication administration workflows in nursing homes.
- Adjusting for resident-level covariates does not address the differences between nursing homes that achieve extensive chemoprophylaxis and those that do not.
- The study acknowledges potential residual bias due to unmeasured factors influencing hospitalization risk.
- Rapid, extensive, staff-administered oseltamivir chemoprophylaxis may decrease short-term hospitalizations during influenza outbreaks.
Clinical Implications
Healthcare professionals should consider the importance of accurate medication administration records when evaluating antiviral strategies in nursing homes.
Conclusion
Further studies are encouraged to validate these results and refine treatment strategies.
Related Resources & Content
- JAMA Internal Medicine, 2023 -- Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks
- JAMA Internal Medicine, 2023 -- Aggressive Antiviral Prophylaxis During Influenza Outbreaks in Long-Term Care Facilities
- The Journal of Infectious Diseases, 2023 -- Antiviral Strategies for Influenza Prevention and Management in Immunocompromised Patients
- International Journal of Infectious Diseases — Comparative Effectiveness of Adjuvanted and High-Dose Influenza Vaccines Against Confirmed Influenza Outcomes, Including Hospitalizations, in Older Adults During the 2022–2023 and 2023–2024 Seasons
- Influenza Antiviral Medications: Summary for Clinicians | CDC
- Viral Respiratory Pathogens Toolkit for Nursing Homes | CDC
- IDSA 2018 Clinical Practice Guideline Update for Influenza
- Influenza Antiviral Medications: Summary for Clinicians | Influenza (Flu) | CDC
- Influenza virus testing in investigational outbreaks in institutional or other closed settings | Influenza (Flu) | CDC
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa | Clinical Infectious Diseases | Oxford Academic
- Antivirals for preventing influenza among persons with exposure to influenza virus but without infection - Clinical practice guidelines for influenza - NCBI Bookshelf
- Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population - PubMed
- Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons - PMC
- Evaluation of Influenza Antiviral Prophylaxis for Long-term Care Residents: A Systematic Review and Meta-Analysis | Clinical Infectious Diseases | Oxford Academic
- Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis - ScienceDirect
Based on findings from:
Intensive Chemoprophylaxis for Nursing Home Influenza Outbreaks—Reply
Andrew R. Zullo, Joe B. B. Silva, Stefan Gravenstein. Jama Internal Medicine, 2026.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2852236
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
